Seeking Alpha

TRVN
  Trevena, Inc. - NASDAQ

8/21/2014, 3:00 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
TRVN vs. ETF Alternatives
Company Description
Trevena Inc is a clinical stage biopharmaceutical company that discovers, develops therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs.
Sector: Healthcare
Industry: Biotechnology
Country: United States